Minimal Residual Disease is a Prognostic Marker for Neuroblastoma With Bone Marrow Infiltration
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference13 articles.
1. Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a Childrens Oncology Group Study.;Matthay;J Clin Oncol,2009
2. Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the childrens oncology group.;Park;Pediatr Blood Cancer,2009
3. High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial.;Pearson;Lancet Oncol,2008
4. Neuroblastoma: therapeutic strategies for a clinical enigma.;Modak;Cancer Treat Rev,2010
5. Real-time RT-PCR of tyrosine hydroxylase to detect bone marrow involvement in advanced neuroblastoma.;Pession;Oncol Rep,2003
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Functionalized GD2 Electrochemical Immunosensor to Diagnose Minimum Residual Disease of Bone Marrow in Neuroblastoma Effectively;Biosensors;2023-10-10
2. Utility of Flow Cytometry Analysis in the Detection of Nonhematologic Neoplasms;Clinics in Laboratory Medicine;2023-09
3. Flow Cytometry Immunophenotyping for Diagnostic Orientation and Classification of Pediatric Cancer Based on the EuroFlow Solid Tumor Orientation Tube (STOT);Cancers;2021-09-30
4. The Application of and Factors Influencing, the NB5 Assay in Neuroblastomas;Frontiers in Oncology;2021-05-14
5. Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma;Journal of Personalized Medicine;2021-02-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3